Income from continuing
operations before
minority interests 16,951 10,928 55,294 22,365
Minority interests in
continuing operations of
consolidated partnerships 51 15 (61) 115
Minority interests in continuing
operations of operating
partnership (545) (497) (1,821) (1,131)
Income from continuing
operations 16,457 10,446 53,412 21,349
Income from discontinued
operations before gain on sale
of assets and minority interests - 383 639 1,156
(Loss)/gain on sale of real
estate assets (1) - 1,087 -
Minority interests attributable
to discontinued operations - (17) (74) (61)
(Loss)/income from
discontinued operations (1) 366 1,652 1,095
Net income 16,456 10,812 55,064 22,444
Preferred stock dividends (4,241) - (12,628) -
Net income available to
common stockholders $12,215 $10,812 $42,436 $22,444
Income from continuing operations
per share available to common
stockholders:
Basic and diluted earnings per
share $0.19 $0.17 $0.62 $0.40
Net income per share available to
common stockholders:
Basic and diluted earnings per
share $0.19 $0.18 $0.65 $0.42
Weighted-average common shares
outstanding:
Basic 65,308,702 60,477,672 65,300,802 52,822,498
Diluted 68,274,908 63,646,647 68,262,086 55,926,343
<
'/>"/>
| SOURCE BioMed Realty Trust, Inc. Copyright©2007 PR Newswire. All rights reserved |